Renovion2 minDr. Robert Ryan joins Renovion, Inc. Board of DirectorsCHAPEL HILL, N.C., March 1, 2018 -- Renovion, Inc., a privately-held biopharmaceutical company developing novel therapeutics for respiratory diseases, includ...
Renovion2 minRenovion Elects Derek Winstanly as Chairman of Board of DirectorsDecember 20, 2017 09:00 AM Eastern Standard Time DURHAM, N.C.--(BUSINESS WIRE)--Renovion, Inc. ("Renovion"), an early stage drug development company targetin...
Renovion2 minRenovion, Inc. Receives Orphan Designation for Arina-1 for the Treatment of Lung Dysfunction followiRenovion, Inc. announced today that the FDA Office of Orphan Products has granted Orphan Designation in the US to the Company's nebulized therapy Arina-1 for...
Renovion2 minChapel Hill startups represent in D.C.Two Chapel Hill-based startups — EpiCypher and Renovion — attended the first University Startups Demo Day in Washington, D.C. CHAPEL HILL, N.C., September 22...
Renovion3 min‘Spirit of innovation’CHAPEL HILL, N.C., September 19, 2016. Of the more than 800 startups created at universities across the country this year, only 35 have been handpicked as th...
Renovion2 minEntrepreneur with GSK roots targets lung transplant survival rates with UNC technologyIn a tiny lab in Chapel Hill, a 3-year-old startup with UNC-Chapel Hill technology is trying to help lung transplant patients defy the odds. CHAPEL HILL, N.C...
Renovion2 minRenovion Receives Patent Allowance for Novel Therapy- Patent claims set foundation for commercialization - Board and management team in place to execute pre-clinical plan CHAPEL HILL, N.C., February 1, 2016 --...
